MELATONINMELTS Trademark

Trademark Overview

On Friday, October 7, 2022, a trademark application was filed for MELATONINMELTS with the United States Patent and Trademark Office. The USPTO has given the MELATONINMELTS trademark a serial number of 97623364. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 3, 2024. This trademark is owned by BRST Labs, LLC. The MELATONINMELTS trademark is filed in the Pharmaceutical Products category with the following description:

Melatonin in solid dosage form to be administered sublingually or buccally
melatoninmelts

General Information

Serial Number97623364
Word MarkMELATONINMELTS
Filing DateFriday, October 7, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMelatonin in solid dosage form to be administered sublingually or buccally

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBRST Labs, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOcala, FL 34476

Trademark Events

Event DateEvent Description
Monday, October 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 11, 2022NEW APPLICATION ENTERED
Friday, July 21, 2023ASSIGNED TO EXAMINER
Tuesday, July 25, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 25, 2023NON-FINAL ACTION E-MAILED
Tuesday, July 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, October 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, January 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 25, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 19, 2024FINAL REFUSAL WRITTEN
Monday, February 19, 2024FINAL REFUSAL E-MAILED
Monday, February 19, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 30, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 30, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, September 3, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, September 3, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

melatoninmelts sublingually buccally administered form solid dosage melatonin